Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Jun;79(2):595–598. doi: 10.1111/j.1476-5381.1983.tb11034.x

Glucocorticoid protection against PAF-acether toxicity in mice.

A Myers, E Ramey, P Ramwell
PMCID: PMC2044884  PMID: 6652344

Abstract

Intravenous platelet activating factor (PAF-acether, 10 to 25 micrograms/kg body weight) produced dose-dependent mortality in both male and female mice. Pretreatment with indomethacin (50 mg/kg), verapamil (40 mg/kg) or nifedipine (4 mg/kg) failed to inhibit the lethal effect of 20 micrograms/kg PAF-acether. This suggests that neither arachidonate cyclo-oxygenase products nor availability of extracellular Ca2+ mediate the toxic action. In contrast, pretreatment with 100 mg/kg cortisone acetate (s.c.) daily for four days exerted a highly protective effect, i.e. 100% and 93% survival in males and females, compared to 13% and 7% respectively, in untreated animals. PAF-acether-induced death may be a useful model for the in vivo evaluation of pharmacological agents in anaphylactic shock.

Full text

PDF
595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson P., Brattsand R. Protective effects of the glucocorticoid, budesonide, on lung anaphylaxis in actively sensitized guinea-pigs: inhibition of IgE-but not of IgG-mediated anaphylaxis. Br J Pharmacol. 1982 May;76(1):139–147. doi: 10.1111/j.1476-5381.1982.tb09199.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blank M. L., Snyder F., Byers L. W., Brooks B., Muirhead E. E. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem Biophys Res Commun. 1979 Oct 29;90(4):1194–1200. doi: 10.1016/0006-291x(79)91163-x. [DOI] [PubMed] [Google Scholar]
  3. Bonnet J., Loiseau A. M., Orvoen M., Bessin P. Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes. Agents Actions. 1981 Dec;11(6-7):559–562. doi: 10.1007/BF01978740. [DOI] [PubMed] [Google Scholar]
  4. Chesney C. M., Pifer D. D., Byers L. W., Muirhead E. E. Effect of platelet-activating factor (PAF) on human platelets. Blood. 1982 Mar;59(3):582–585. [PubMed] [Google Scholar]
  5. Chignard M., Vargaftig B. B., Benveniste J., Le Couedic J. P. L'agrégation plaquettaire et le platelet-activating factor. J Pharmacol. 1980 Oct-Dec;11(4):371–377. [PubMed] [Google Scholar]
  6. Chignard M., Wal F., Lefort J., Vargaftig B. B. Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig. Eur J Pharmacol. 1982 Feb 19;78(1):71–79. doi: 10.1016/0014-2999(82)90373-9. [DOI] [PubMed] [Google Scholar]
  7. Kohler C., Wooding W., Ellenbogen L. Intravenous arachidonate in the mouse: a model for the evaluation of antithrombotic drugs. Thromb Res. 1976 Jul;9(1):67–80. doi: 10.1016/0049-3848(76)90150-x. [DOI] [PubMed] [Google Scholar]
  8. McManus L. M., Hanahan D. J., Demopoulos C. A., Pinckard R. N. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J Immunol. 1980 Jun;124(6):2919–2924. [PubMed] [Google Scholar]
  9. McManus L. M., Pinckard R. N., Fitzpatrick F. A., O'Rourke R. A., Crawford M. H., Hanahan D. J. Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon. Lab Invest. 1981 Oct;45(4):303–307. [PubMed] [Google Scholar]
  10. Moore P. K., Hoult J. R. Pathophysiological states modify levels in rat plasma of factors which inhibit synthesis and enhance breakdown of PG. Nature. 1980 Nov 20;288(5788):271–273. doi: 10.1038/288271a0. [DOI] [PubMed] [Google Scholar]
  11. Myers A., Penhos J., Ramey E., Ramwell P. Thromboxane agonism and antagonism in a mouse sudden death model. J Pharmacol Exp Ther. 1983 Feb;224(2):369–372. [PubMed] [Google Scholar]
  12. Okamatsu S., Peck R. C., Lefer A. M. Effect of calcium channel blockers on arachidonate-induced sudden death in rabbits. Proc Soc Exp Biol Med. 1981 Apr;166(4):551–555. doi: 10.3181/00379727-166-41107. [DOI] [PubMed] [Google Scholar]
  13. Penhos J. C., Montalbert-Smith M., Rabbani F., Ramey E., Ramwell P. W. Effect of corticosteroids on arachidonate induced mortality in male and female mice. Prostaglandins. 1979 Nov;18(5):697–706. doi: 10.1016/0090-6980(79)90090-x. [DOI] [PubMed] [Google Scholar]
  14. Pinckard R. N., Halonen M., Palmer J. D., Butler C., Shaw J. O., Henson P. M. Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. J Immunol. 1977 Dec;119(6):2185–2193. [PubMed] [Google Scholar]
  15. Rabbani F., Myers A., Ramey E., Ramwell P., Penhos J. Acute protection against arachidonate toxicity by hydrocortisone and dexamethasone in mice. Prostaglandins. 1981 May;21(5):699–704. doi: 10.1016/0090-6980(81)90227-6. [DOI] [PubMed] [Google Scholar]
  16. Saeed S. A., Drew M., Collier H. O. Endogenous inhibitors of lipoxygenase. Eur J Pharmacol. 1980 Oct 3;67(1):169–170. doi: 10.1016/0014-2999(80)90030-8. [DOI] [PubMed] [Google Scholar]
  17. Saeed S. A., McDonald-Gibson W. J., Cuthbert J., Copas J. L., Schneider C., Gardiner P. J., Butt N. M., Collier H. O. Endogenous inhibitor of prostaglandin synthetase. Nature. 1977 Nov 3;270(5632):32–36. doi: 10.1038/270032a0. [DOI] [PubMed] [Google Scholar]
  18. Vargaftig B. B., Chignard M., Benveniste J., Lefort J., Wal F. Background and present status of research on platelet-activating factor (PAF-acether). Ann N Y Acad Sci. 1981;370:119–137. doi: 10.1111/j.1749-6632.1981.tb29727.x. [DOI] [PubMed] [Google Scholar]
  19. Vargaftig B. B., Lefort J., Chignard M., Benveniste J. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol. 1980 Jul 25;65(2-3):185–192. doi: 10.1016/0014-2999(80)90391-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES